paranasal sinus and nasal cavity cancer
Showing 1 - 25 of >10,000
Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer Trial in Shanghai (endoscopic surgery)
Recruiting
- Sarcoma,Soft Tissue
- +3 more
- endoscopic surgery
-
Shanghai, Shanghai, ChinaYu Hongmeng
Nov 7, 2022
Paranasal Sinus Cancer, Nasal Cavity Tumor, Nasal Cavity Adenocarcinoma Trial in United States (drug, radiation, procedure)
Completed
- Paranasal Sinus Cancer
- +2 more
- Cisplatin
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jan 17, 2023
Nasal Cavity Cancer, Paranasal Sinus Cancer, Camrelizumab Trial in Guangzhou (camrelizumab)
Recruiting
- Nasal Cavity Cancer
- +5 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 9, 2021
Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2022
Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly
Recruiting
- Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
- +6 more
- Carboplatin
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jul 23, 2021
Fungal Sinusitis Trial in Ostrava (Samplings from patient's affected paranasal sinus)
Recruiting
- Fungal Sinusitis
- Samplings from patient's affected paranasal sinus
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava, Department of Otorhinolaryngology a
Jul 24, 2023
European Reference Network on Rare Adult Solid Cancers
Recruiting
- Head and Neck Cancer
- +4 more
- observation
-
Brno, Czechia
- +10 more
Aug 1, 2022
Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester
Recruiting
- Head and Neck Carcinoma
- +10 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 6, 2023
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Squamous Cell Carcinoma, the Nasal Cavity, Paranasal Sinuses Trial in Houston (Pembrolizumab, Docetaxel, Cisplatin)
Recruiting
- Squamous Cell Carcinoma
- +2 more
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Nasal Cavity and Paranasal Sinus
Recruiting
- Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
- Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7
- Carboplatin
- +7 more
-
Tucson, Arizona
- +139 more
Dec 7, 2022
Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base
Recruiting
- Tumors
- Standard of Care
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2023
Chronic Sinus Disease, Surgery Trial in Los Angeles (PuraSinus, Bioresorbable Nasal Dressing)
Recruiting
- Chronic Sinus Disease
- Surgery
- PuraSinus
- Bioresorbable Nasal Dressing
-
Los Angeles, CaliforniaKeck Medical Center
Jan 27, 2022
Nasal Tumor, Nasal Tumor Benign, Skull Base Tumors Trial in Ljubljana
Recruiting
- Nasal Neoplasm
- +5 more
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Nov 3, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Kalydeco on Upper Airway and Paranasal Sinus Inflammation
Completed
- Inflammatory Changes in Epithelial Lining Fluid Sampled Non-invasively by Nasal Lavage in CF Patients With G551D Receiving Kalydeco
- nasal lavage (routine diagnostic procedure in our centre), assessment of symptoms
-
Jena, GermanyJena University Hospital, CF Center
Jul 8, 2021
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Sinusitis Trial in San Francisco, Salt Lake City (3NT flexible endoscope)
Completed
- Sinusitis
- 3NT flexible endoscope
-
San Francisco, California
- +1 more
Dec 7, 2020
Head and Neck Carcinoma, Malignant Parotid Gland Tumor, Maxillary Sinus Carcinoma Trial in United States (Best Practice, Medical
Recruiting
- Head and Neck Carcinoma
- +6 more
- Best Practice
- Medical Device Usage and Evaluation
-
Phoenix, Arizona
- +3 more
Oct 10, 2022
Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous
Completed
- Head and Neck Cancer
- +19 more
- lapatinib ditosylate
- capecitabine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Mar 6, 2020